Aventis Lantus Approved For Use With Insulin Delivery Device
This article was originally published in The Pink Sheet Daily
Executive Summary
The OptiClick reusable “pen” injection system will be used with insulin products Lantus, Apidra; both had been approved for subcutaneous injection. Aventis has not announced its launch plans for OptiClick.
You may also be interested in...
Sanofi-Aventis’ Insulin Pen Prone To Medication Errors – ISMP
OptiClik insulin delivery system’s digital display, when incorrectly oriented, may cause overdosing or subtherapeutic dosing, according to Medication Safety Alert.
Sanofi-Aventis’ Insulin Pen Prone To Medication Errors – ISMP
OptiClik insulin delivery system’s digital display, when incorrectly oriented, may cause overdosing or subtherapeutic dosing, according to Medication Safety Alert.
Sanofi's Diabetes Sales Force Increase Not Due To Threat From Exubera Or Levemir, Exec Says
Sanofi attributes its increased detailing focus on the diabetes market to changing prescribing trends, not increased competition.